Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 1.16% is 51% below its 5-year average of 2.38%, near the low end of its 5-year range (0.68%–3.43%).
As of the fiscal period ended Wednesday, December 31, 2025. 7.20% below its 12-month average of 1.25%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
1.16%
RETURN ON ASSETS (ROA) AVG TTM
1.25%
RETURN ON ASSETS (ROA) AVG 3Y
1.93%
RETURN ON ASSETS (ROA) AVG 5Y
2.38%
RETURN ON ASSETS (ROA) AVG 10Y
3.20%
RETURN ON ASSETS (ROA) AVG 15Y
4.04%
RETURN ON ASSETS (ROA) AVG 20Y
4.54%
CURRENT VS TTM AVG
-7.20%
CURRENT VS 3Y AVG
-39.97%
CURRENT VS 5Y AVG
-51.23%
CURRENT VS 10Y AVG
-63.76%
CURRENT VS 15Y AVG
-71.27%
CURRENT VS 20Y AVG
-74.45%
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-76.47%
vs the sector median at left
CVS Health Corp.
Market Cap
$137.47B
Return on Assets (ROA)
1.16%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$134.62B
Return on Assets (ROA)
4.33%
TTM Avg
4.68%
3Y Avg
5.89%
5Y Avg
6.01%
Market Cap
$126.79B
Return on Assets (ROA)
8.41%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$126.60B
Return on Assets (ROA)
7.21%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$121.16B
Return on Assets (ROA)
16.38%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
Market Cap
$119.23B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$160.55B
Return on Assets (ROA)
16.38%
TTM Avg
7.62%
3Y Avg
7.90%
5Y Avg
6.83%
Market Cap
$106.51B
Return on Assets (ROA)
5.16%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVS Health Corp. (CVS) | $137.47B | 1.16% | 1.25% | 1.93% | 2.38% |
| Pfizer Inc. (PFE)vs › | $139.86B | 3.61% | 3.75% | 6.08% | 7.08% |
| Danaher Corporation (DHR)vs › | $134.62B | 4.33% | 4.68% | 5.89% | 6.01% |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | 8.41% | -0.92% | 3.28% | 1.99% |
| Stryker Corporation (SYK)vs › | $126.60B | 7.21% | 6.88% | 7.02% | 6.41% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.16B | 16.38% | 6.37% | 11.74% | 14.58% |
| Intuitive Surgical, Inc. (ISRG)vs › | $119.23B | 15.04% | 13.09% | 12.00% | 11.68% |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | 16.38% | 7.62% | 7.90% | 6.83% |
| Medtronic plc (MDT)vs › | $106.51B | 5.16% | 5.13% | 4.62% | 4.65% |
| GSK plc (GSK)vs › | $103.60B | 7.15% | 6.85% | 11.28% | 9.07% |
ROA
1.2%
ROE
3.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 0.68% |
| 2024-12-31 | 1.82% |
| 2023-12-31 | 3.34% |
| 2022-12-31 | 1.89% |
| 2021-12-31 | 3.43% |
| 2020-12-31 | 3.11% |
| 2019-12-31 | 2.98% |
| 2018-12-31 | -0.30% |
| 2017-12-31 | 6.96% |
| 2016-12-31 | 5.63% |
| 2015-12-31 | 5.67% |
| 2014-12-31 | 6.26% |
| 2013-12-31 | 6.42% |
| 2012-12-31 | 5.84% |
| 2011-12-31 | 5.36% |
| 2010-12-31 | 5.51% |
| 2009-12-31 | 6.00% |
| 2008-12-31 | 5.27% |
| 2007-12-31 | 4.82% |
| 2006-12-31 | 6.65% |
| 2005-12-31 | 8.01% |
| 2004-12-31 | 6.32% |
| 2003-12-31 | 8.04% |
| 2002-12-31 | 7.43% |
| 2001-12-31 | 4.78% |
| 2000-12-31 | 9.38% |
| 1999-12-31 | 8.73% |
| 1998-12-31 | 5.75% |
| 1997-12-31 | 1.49% |
| 1996-12-31 | 3.66% |
